Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil E Fleshner

Showing results (201-210 of 292) with videos related to

Pageof 30
Sort By:
Surgical Oncology|June 26, 2018
Prehabilitation for radical prostatectomy: A multicentre randomized controlled trialDaniel Santa Mina, William J Hilton, Andrew G Matthew, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2019
A Phase 1 Pilot Study of Preoperative Radiation Therapy for Prostate Cancer: Long-Term Toxicity and Oncologic OutcomesRachel Glicksman, Noelia Sanmamed, John Thoms, et al.
Cancer Medicine|June 16, 2018
Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancerStephen Yiu Chuen Choi, Susan L Ettinger, Dong Lin, et al.
Urology|March 27, 2016
Influence of Metabolic Syndrome on Prostate Cancer Stage, Grade, and Overall Recurrence Risk in Men Undergoing Radical ProstatectomyBimal Bhindi, Wen Y Xie, Girish S Kulkarni, et al.
BJU International|August 20, 2011
Sex differences in bladder cancer outcomes among smokers with advanced bladder cancerPeter J Boström, Sultan Alkhateeb, Greg Trottier, et al.
British Journal of Cancer|December 15, 2015
Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomyBimal Bhindi, Thomas Hermanns, Yanliang Wei, et al.
BJU International|December 17, 2009
Pathological stage review is indicated in primary pT1 bladder cancerBas W G van Rhijn, Theo H van der Kwast, David M Kakiashvili, et al.
Clinical Chemistry|August 21, 2013
MicroRNA signature helps distinguish early from late biochemical failure in prostate cancerZsuzsanna Lichner, Annika Fendler, Carol Saleh, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 14, 2022
Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in CanadaShamini Selvarajah, Kasmintan A Schrader, Michael P Kolinsky, et al.
Journal of the American Medical Informatics Association : JAMIA|August 6, 2011
Point-of-care clinical documentation: assessment of a bladder cancer informatics tool (eCancerCareBladder): a randomized controlled study of efficacy, efficiency and user friendliness compared with standard electronic medical recordsPeter J Bostrom, Paul J Toren, Hao Xi, et al.
Pageof 30

Showing results (201-210 of 292) with videos related to

Sort By:
Pageof 30
Surgical Oncology|June 26, 2018
Prehabilitation for radical prostatectomy: A multicentre randomized controlled trialDaniel Santa Mina, William J Hilton, Andrew G Matthew, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2019
A Phase 1 Pilot Study of Preoperative Radiation Therapy for Prostate Cancer: Long-Term Toxicity and Oncologic OutcomesRachel Glicksman, Noelia Sanmamed, John Thoms, et al.
Cancer Medicine|June 16, 2018
Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancerStephen Yiu Chuen Choi, Susan L Ettinger, Dong Lin, et al.
Urology|March 27, 2016
Influence of Metabolic Syndrome on Prostate Cancer Stage, Grade, and Overall Recurrence Risk in Men Undergoing Radical ProstatectomyBimal Bhindi, Wen Y Xie, Girish S Kulkarni, et al.
BJU International|August 20, 2011
Sex differences in bladder cancer outcomes among smokers with advanced bladder cancerPeter J Boström, Sultan Alkhateeb, Greg Trottier, et al.
British Journal of Cancer|December 15, 2015
Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomyBimal Bhindi, Thomas Hermanns, Yanliang Wei, et al.
BJU International|December 17, 2009
Pathological stage review is indicated in primary pT1 bladder cancerBas W G van Rhijn, Theo H van der Kwast, David M Kakiashvili, et al.
Clinical Chemistry|August 21, 2013
MicroRNA signature helps distinguish early from late biochemical failure in prostate cancerZsuzsanna Lichner, Annika Fendler, Carol Saleh, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 14, 2022
Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in CanadaShamini Selvarajah, Kasmintan A Schrader, Michael P Kolinsky, et al.
Journal of the American Medical Informatics Association : JAMIA|August 6, 2011
Point-of-care clinical documentation: assessment of a bladder cancer informatics tool (eCancerCareBladder): a randomized controlled study of efficacy, efficiency and user friendliness compared with standard electronic medical recordsPeter J Bostrom, Paul J Toren, Hao Xi, et al.
Pageof 30